bmiMD vs Willow: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent research·How we rank →

bmiMD beats Willow overall, scoring 8/10 vs 7.5/10. bmiMD is more affordable at $119/mo vs $299/mo. Choose bmiMD for users who want an established, large-scale platform with sam. Choose Willow for users who want comprehensive clinical support with flexibili.

A side-by-side look at bmiMD and Willow to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

bmiMD

#6 of 52

8/10

Budget-friendly GLP-1 platform offering both medication types at one of the lowest price points in the market.

Visit bmiMD

Willow

#24 of 52

7.5/10

Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only, Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Added oral compounded semaglutide tablets as a non-injectable option.

Visit Willow

Feature	bmiMD	Willow
Our Score	8/10	7.5/10
Starting Price	$119/mo	$299/mo
Medication Type	Both	Compounded
Insurance Accepted	No	No
Best For	Users who want an established, large-scale platform with same-day consults and strong promo pricing	Users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes
Ranking	#6	#24
Get started	Visit bmiMD	Visit Willow

Pros & Cons Compared

bmiMD

Pros

+Same-day physician consults, one of the few platforms offering telehealth appointments the same day you apply
+80,000+ customer base with 4.9-star Trustpilot rating provides strong social proof of reliability
+100% money-back guarantee if your consultation determines you don't qualify for GLP-1 treatment
+HSA/FSA accepted for all programs

Cons

−Standard semaglutide pricing is $289/mo, above competitors at $99-199/mo; the TAKEOFF 3-month entry (about $99/mo first month) and annual plans from $99/mo bring the effective rate down
−$29.99 shipping fee per order where most competitors ship free; factor it into your monthly total
−A $50 non-refundable cancellation fee applies after intake approval; decide before the consult, and cancel at least 48 hours ahead of your monthly processing date

Willow

Pros

+Includes monthly provider check-ins and dose adjustments at no extra cost
+Offers both injectable AND oral compounded semaglutide, one of few platforms with a daily oral tablet option
+$299/mo all-in for compounded semaglutide with monthly provider support
+90%+ patient retention rate after 3 months per their published outcomes data

Cons

−Compounded-only, no brand-name Wegovy or Zepbound through the platform
−Tirzepatide pricing reaches $499-$524 at higher doses, starting dose is $399/mo
−Cash-pay only, no insurance billing, though they provide superbills for FSA/HSA
−Founded in 2024, less track record than Ro or Hims, though growth has been fast

Our Verdict

bmiMD edges out Willow with a score of 8/10 vs 7.5/10. If budget is your priority, bmiMD starts at $119/mo compared to Willow's $299/mo. bmiMD offers both brand-name and compounded medications, giving you more flexibility. Choose bmiMD if you want: users who want an established, large-scale platform with same-day consults and strong promo pricing. Choose Willow if you want: users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither bmiMD nor Willow feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Visit Yucca Health→Read our full Yucca Health review